User Tools

Site Tools


algae:plant_protection

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Next revision
Previous revision
algae:plant_protection [2026-09-13 21:52] – created robertalgae:plant_protection [2026-09-13 22:07] (current) – [Level 1: Approval of the active substance at EU level] robert
Line 1: Line 1:
 ===== Plant Protection Products ===== ===== Plant Protection Products =====
  
-Algae-derived compounds and extracts are increasingly used in agriculture as crop inputs with protective or stimulating effects. Depending on the claimed function and mechanism of action, these products may fall under one of two fundamentally different EU regulatory frameworks: the Fertilising Products Regulation (EU) 2019/1009 — in particular its biostimulant provisions — or Regulation (EC) No 1107/2009 on plant protection products (PPP). The distinction between these two pathways is one of the most practically consequential classification decisions an algae producer can face, because the data requirements, authorisation timelines and market access costs differ by an order of magnitude.+Algae-derived compounds and extracts are increasingly used in agriculture as crop inputs with protective or stimulating effects. Depending on the claimed function and mechanism of action, these products may fall under one of two fundamentally different EU regulatory frameworks: the Fertilising Products Regulation (EU) 2019/1009 [[https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02019R1009-20251230|EURlex]] — in particular its biostimulant provisions — or Regulation (EC) No 1107/2009 on plant protection products (PPP) [[https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02009R1107-20221121|EURlex]]. The distinction between these two pathways is one of the most practically consequential classification decisions an algae producer can face, because the data requirements, authorisation timelines and market access costs differ by an order of magnitude.
  
 This chapter covers the PPP framework and the biostimulant/biopesticide boundary. The biostimulant pathway under the FPR is discussed in [[algae:fertiliser_products|Fertilising Products and Biostimulants]]. This chapter covers the PPP framework and the biostimulant/biopesticide boundary. The biostimulant pathway under the FPR is discussed in [[algae:fertiliser_products|Fertilising Products and Biostimulants]].
Line 34: Line 34:
 === Low-risk active substances and basic substances === === Low-risk active substances and basic substances ===
  
-Regulation (EC) No 1107/2009 contains two provisions relevant to algae-derived PPPs that offer a lighter pathway:+Regulation (EC) No 1107/2009 [[https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02009R1107-20221121|EURlex]] contains two provisions relevant to algae-derived PPPs that offer a lighter pathway:
  
   * __Low-risk active substances__ (Article 22): substances that pose a low risk to human health, animal health and the environment may be approved with reduced data requirements and faster timelines. To qualify, the substance must be non-toxic, non-mutagenic and not a persistent organic pollutant, among other criteria. Several algae-derived substances could potentially qualify, but approval still requires a full application to EFSA.   * __Low-risk active substances__ (Article 22): substances that pose a low risk to human health, animal health and the environment may be approved with reduced data requirements and faster timelines. To qualify, the substance must be non-toxic, non-mutagenic and not a persistent organic pollutant, among other criteria. Several algae-derived substances could potentially qualify, but approval still requires a full application to EFSA.
Line 51: Line 51:
 Before any PPP containing an algae-derived active substance can be authorised in any member state, the active substance itself must be approved at EU level. The procedure: Before any PPP containing an algae-derived active substance can be authorised in any member state, the active substance itself must be approved at EU level. The procedure:
  
-  1. Applicant submits a complete dossier (including identity, physical/chemical properties, efficacy data, toxicological studies, ecotoxicological studies, environmental fate and behaviour, residue data in crops, and analytical methods) to a Rapporteur Member State and to EFSA. +  -   Applicant submits a complete dossier (including identity, physical/chemical properties, efficacy data, toxicological studies, ecotoxicological studies, environmental fate and behaviour, residue data in crops, and analytical methods) to a Rapporteur Member State and to EFSA. 
-  2. The Rapporteur Member State prepares a Draft Assessment Report (DAR). +  -   The Rapporteur Member State prepares a Draft Assessment Report (DAR). 
-  3. EFSA conducts a peer review of the DAR, including a public consultation. +  -   EFSA conducts a peer review of the DAR, including a public consultation. 
-  4. EFSA issues a conclusion on the active substance. +  -   EFSA issues a conclusion on the active substance. 
-  5. The European Commission adopts an implementing regulation approving or not approving the active substance, with specified conditions of use.+  -   The European Commission adopts an implementing regulation approving or not approving the active substance, with specified conditions of use.
  
 This process takes a minimum of 3–5 years and costs several million euros in study generation and application fees for conventional chemistry. For biological substances (including algae-derived materials), data requirements may be somewhat reduced — particularly for toxicological endpoints where a long history of safe use can substitute for some animal studies — but the fundamental structure of the dossier remains the same. This process takes a minimum of 3–5 years and costs several million euros in study generation and application fees for conventional chemistry. For biological substances (including algae-derived materials), data requirements may be somewhat reduced — particularly for toxicological endpoints where a long history of safe use can substitute for some animal studies — but the fundamental structure of the dossier remains the same.
algae/plant_protection.1789336339.txt.gz · Last modified: by robert